Extracellular ATP has been shown to play an important role in invasion and the epithelialâmesenchymal transition (EMT) process in breast cancer; however, the mechanism is unclear. Here, by using a cDNA microarray, we demonstrated that extracellular ATP could stimulate hypoxiaâinducible factor (HIF) signaling and upregulate hypoxiaâinducible factor 1/2α (HIFâ1/2α) expression. After knocking down HIFâ1/2α using siRNA, we found that ATPâdriven invasion and EMT were significantly attenuated via HIF2AâsiRNA in breast cancer cells. By using ChIP assays, we revealed that the biological function of extracellular ATP in invasion and EMT process depended on HIFâ2α direct targets, among which lysyl oxidaseâlike 2 (LOXL2) and matrix metalloproteinaseâ9 (MMPâ9) mediated ATPâdriven invasion, and Eâcadherin and Snail mediated ATPâdriven EMT, respectively. In addition, using silver staining and mass spectrometry, we found that phosphoglycerate kinase 1 (PGK1) could interact with HIFâ2α and mediate ATPâdriven HIFâ2α upregulation. Furthermore, we demonstrated that expressions of HIFâ2α and its target proteins could be regulated via ATP by AKTâPGK1 pathway. Using a Balb/c mice model, we illustrated the function of HIFâ2α in promoting tumor growth and metastasis in vivo. Moreover, by exploring online databases, we found that molecules involved in ATPâHIFâ2α signaling were highly expressed in human breast carcinoma tissues and were associated with poor prognosis. Altogether, these findings suggest that extracellular ATP could promote breast carcinoma invasion and EMT via HIFâ2α signaling, which may be a potential target for future antiâmetastasis therapy.